Clinical Trials Browser

Phase 1/2 × Unknown × Carcinoma, Transitional Cell × Clear all

NCT04565275 2023-03-14

A Study of ICP-192 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

GastrointestinalGenitourinary

Carcinoma, Transitional Cell, Cholangiocarcinoma

NCT03475953 2023-03-03

REGOMUNE

Phase 1/2 Unknown

BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

NCT05086666 2021-10-21

A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547

Phase 1/2 Unknown

Carcinoma, Transitional Cell

NCT04264936 2020-02-13

A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer

Phase 1/2 Unknown

Carcinoma, Transitional Cell

NCT03676946 2018-09-26

A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma

Phase 1/2 Unknown

Carcinoma, Transitional Cell